Form 8-K - Current report:
SEC Accession No. 0001193125-24-210399
Filing Date
2024-08-30
Accepted
2024-08-30 08:15:55
Documents
13
Period of Report
2024-08-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d884852d8k.htm   iXBRL 8-K 27441
  Complete submission text file 0001193125-24-210399.txt   150536

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20240829.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20240829_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20240829_pre.xml EX-101.PRE 11257
15 EXTRACTED XBRL INSTANCE DOCUMENT d884852d8k_htm.xml XML 3642
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 241266036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)